Measuring endogenous 5-HT release by emission tomography: promises and pitfalls

LM Paterson, RJ Tyacke, DJ Nutt… - Journal of Cerebral …, 2010 - journals.sagepub.com
Molecular in vivo neuroimaging techniques can be used to measure regional changes in
endogenous neurotransmitters, evoked by challenges that alter synaptic neurotransmitter …

Decoding neurotransmitter switching: the road forward

H Li, M Pratelli, S Godavarthi, S Zambetti… - Journal of …, 2020 - Soc Neuroscience
Neurotransmitter switching is a form of brain plasticity in which an environmental stimulus
causes neurons to replace one neurotransmitter with another, often resulting in changes in …

PET imaging reveals brain functional changes in internet gaming disorder

M Tian, Q Chen, Y Zhang, F Du, H Hou, F Chao… - European Journal of …, 2014 - Springer
Background Internet gaming disorder is an increasing problem worldwide, resulting in
critical academic, social, and occupational impairment. However, the neurobiological …

Therapeutic doses of amphetamine or methylphenidate differentially increase synaptic and extracellular dopamine

WK Schiffer, ND Volkow, JS Fowler, DL Alexoff… - Synapse, 2006 - Wiley Online Library
Methylphenidate (MP) and amphetamine (AMP) are first‐line treatments for attention‐deficit
hyperactivity disorder. Although both drugs have similar therapeutic potencies, the …

Effects of reduced endogenous 5‐HT on the in vivo binding of the serotonin transporter radioligand 11C‐DASB in healthy humans

PS Talbot, WG Frankle, DR Hwang, Y Huang… - Synapse, 2005 - Wiley Online Library
Abstract Although abnormal serotonin (5‐HT) function is implicated in a range of mental
disorders, there is currently no method to directly assess 5‐HT synaptic levels in the living …

Occupancy of agonist drugs at the 5-HT1A receptor

RA Bantick, EA Rabiner, E Hirani… - …, 2004 - nature.com
Drugs acting on the 5-HT 1A receptor are used in the treatment of depression, generalized
anxiety disorder, and schizophrenia. This study investigated 5-HT 1A receptor occupancy by …

A reduced extracellular serotonin level increases the 5-HT1A PET ligand 18F-MPPF binding in the rat hippocampus

L Zimmer, L Rbah, F Giacomelli… - Journal of Nuclear …, 2003 - Soc Nuclear Med
4, 2′-(Methoxyphenyl)-1-[2′-(N-2 ″-pyridinyl)-p-fluorobenzamido] ethylpiperazine (18F-
MPPF) is a radiotracer used in clinical PET studies for the visualization of serotonin-1A (5 …

PET neurochemical imaging modes

MS Placzek, W Zhao, HY Wey, TM Morin… - Seminars in nuclear …, 2016 - Elsevier
PET has deep roots in neuroscience stemming from its first application in brain tumor and
brain metabolism imaging. PET emerged over the past few decades and continues to play a …

Pharmacological blockade and genetic absence of the dopamine D2 receptor specifically modulate voluntary locomotor activity in mice

F Klinker, K Hasan, W Paulus, MA Nitsche… - Behavioural brain …, 2013 - Elsevier
Dopaminergic signaling influences physical activity. Notably impaired D2 receptor (D2R)
function has been associated with decreased voluntary physical activity. Most animal …

[18F]altanserin Binding to Human 5HT2A Receptors is Unaltered after Citalopram and Pindolol Challenge

LH Pinborg, KH Adams, S Yndgaard… - Journal of Cerebral …, 2004 - journals.sagepub.com
The aim of the present study was to develop an experimental paradigm for the study of
serotonergic neurotransmission in humans using positron emission tomography and the 5 …